Condensed Consolidated Balance Sheets - USD ($)
|
Aug. 31, 2022 |
Feb. 28, 2022 |
| Current assets |
|
|
| Cash and cash equivalents |
$ 23,000,391
|
$ 44,061,427
|
| Sales tax, tax credits and other receivables (Note 3) |
1,803,898
|
1,716,262
|
| Inventories (Note 4) |
330,462
|
0
|
| Prepaid expenses and deposits (Note 5) |
4,000,012
|
2,965,646
|
| Assets held for sale (Note 6) |
3,282,515
|
3,389,279
|
| Total current assets |
32,417,278
|
52,132,614
|
| Investment in joint venture |
380,922
|
380,922
|
| Property, plant and equipment, net (Note 7) |
5,340,072
|
5,692,862
|
| Intangible assets, net (Note 8) |
1,081,704
|
1,013,801
|
| Total assets |
39,219,976
|
59,220,199
|
| Current liabilities |
|
|
| Accounts payable and accrued liabilities (Note 10) |
6,908,760
|
9,846,815
|
| Current portion of long-term debt (Note 11) |
250,603
|
0
|
| Total current liabilities |
7,159,363
|
9,846,815
|
| Long-term debt (Note 11) |
3,099,019
|
3,378,403
|
| Total liabilities |
10,258,382
|
13,225,218
|
| Stockholders' Equity |
|
|
| Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding |
0
|
0
|
| Common stock par value $0.0001; 250,000,000 shares authorized; 47,400,709 shares issued and outstanding (February 28, 2022 - 47,388,056) (Note 13) |
4,741
|
4,740
|
| Additional paid-in capital |
169,300,723
|
150,396,704
|
| Additional paid-in capital - Warrants (Note 18) |
20,463,464
|
30,272,496
|
| Accumulated deficit |
(160,294,031)
|
(134,582,926)
|
| Accumulated other comprehensive loss |
(513,303)
|
(96,033)
|
| Total stockholders' equity |
28,961,594
|
45,994,981
|
| Total liabilities and stockholders' equity |
$ 39,219,976
|
$ 59,220,199
|